Spain· ES:1231757001
ORSERDU 86 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A elacestrant product containing elacestrant, registered in Spain by Stemline Therapeutics B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Elacestrant is registered in 14 of 19 countries.
Countries holding a registration under ATC L02BA04 (elacestrant), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 10 of them publish a price we can compare per daily dose
Elacestrant · ATC L02BA04
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of elacestrant costs, country by country.
Normalised to the WHO defined daily dose (0.345 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Elacestrant · price per daily dose (0.345 g)
USD · FX 28 Sept 2026
- CH Switzerland$374.12
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- elacestrant
- Manufacturer
- Stemline Therapeutics B.V.
- Country
- Spain (ES)
- ATC code
- L02BA04
- ATC class
- Elacestrant
- Defined daily dose
- 0.345 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elacestrant in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesORSERDUStemline Therapeutics, Inc.
- SwitzerlandOrserdu 86 mg, FilmtablettenStemline Therapeutics Switzerland GmbH
- CzechiaORSERDUStemline Therapeutics B.V., Amsterdam
- FinlandORSERDUStemline Therapeutics B.V.
- FranceORSERDU 86 mg, comprimé pelliculéSTEMLINE THERAPEUTICS (PAYS-BAS)
- BelgiumOrserdu 86 mgStemline Therapeutics
- IcelandOrserduStemline Therapeutics B.V.
- NetherlandsORSERDU 86 mg filmomhulde tablettenStemline Therapeutics B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Orserdu
- Liechtenstein · Orserdu
- Norway · Orserdu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/69f5dbcc-1a9e-42a4-86b7-7abf03091905 GET /v1/drugs/69f5dbcc-1a9e-42a4-86b7-7abf03091905?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1712234239000}",
"nregistro": "1231757001",
"substance": "elacestrant"
}See everything about elacestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.